Deoxybrevianamide E

• Description :

  Deoxybrevianamide E, an indole alkaloid, is a biosynthetic precursor for advanced metabolites isolated from the marine-derived Aspergillus sp.[1].

• UNSPSC :

  12352005

• Target :

  Endogenous Metabolite

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/deoxybrevianamide-e.html

• Purity :

  99.2

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(N[C@H](C1=O)CC2=C(NC3=C2C=CC=C3)C(C)(C=C)C)[C@]4(N1CCC4)[H]

• Molecular Formula :

  C21H25N3O2

• Molecular Weight :

  351.44

• References & Citations :

  [1]Hikaru Kato, et al. Study on the biosynthesis of the notoamides: Pinacol-type rearrangement of the isoprenyl unit in deoxybrevianamide E and 6-hydroxydeoxybrevianamide E. Tetrahedron Lett. 2011 Dec 21;52 (51) :6923-6926.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• Isoform :

  Microbial Metabolite

• CAS Number :

  [34610-68-9]